0
0
In a pioneering scientific collaboration, IBM and Moderna have successfully used quantum computing technology to predict the secondary protein structure of a 60-nucleotide-long mRNA sequence—the longest ever simulated on quantum hardware. This feat, achieved using IBM’s R2 Heron quantum processor equipped with 80 qubits, marks a significant advancement beyond the previous record of 42 nucleotides and offers promising new pathways in mRNA vaccine design and therapeutic development.
Traditional computational methods struggle with the complexity of modeling mRNA secondary structures, especially intricate features like pseudoknots, due to enormous computational demands. By framing the mRNA folding challenge as an optimization puzzle scored by predicted free energy, the quantum approach enables exploration of a wider range of stable mRNA designs more efficiently than classical methods allow.
The research utilizes a specialized quantum algorithm based on Conditional Value at Risk (CVaR), imported from financial risk assessment, to optimize the quantum processor’s output. The collaboration not only demonstrated the capability of quantum-enhanced simulations at an unprecedented scale but also showcased hybrid quantum-classical computing pipelines designed to complement existing classical computational techniques.
Looking forward, the collaboration plans to extend these methods to larger quantum systems involving up to 156 qubits, aiming to further speed and scale mRNA secondary structure prediction. This integrated approach could accelerate breakthroughs in biotechnology and personalized medicine, ultimately enhancing human health through better-design RNA-based therapeutics.
Disclaimer: This article summarizes recent research developments in quantum computing and biotechnology. The described quantum simulations represent a cutting-edge research application and may not directly translate into immediate clinical or commercial tools. Readers should note that quantum computing technology is evolving rapidly, and practical outcomes depend on ongoing research progress. This article is for informational purposes only and does not constitute medical or investment advice. Always consult qualified professionals for guidance in scientific, medical, or financial matters.
